Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines

By Hanke Tomáš  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 601-616

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections

By Zhou Dongming   Ertl Hildegund CJ  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 1, 2006-01 ,pp. : 63-72

Informa Healthcare

Access to resources Recommend Favorite

Improved outlook on HIV-1 prevention and vaccine development

By Vasan Sandhya   Michael Nelson L  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 983-994

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis vaccine development: research, regulatory and clinical strategies

By Brennan Michael J   Morris Sheldon L   Sizemore Christine F  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1493-1504

Informa Healthcare

Access to resources Recommend Favorite

Supraphysiological expression of survival motor neuron protein from an adenovirus vector does not adversely affect cell function

By McFall Emily R.   Wong Carmen M.   Kothary Rashmi   Parks Robin J.  

Biochemistry and Cell Biology, Vol. 91, Iss. 4, 2013-03 ,pp. : 252-264

NRC Research Press

Access to resources Recommend Favorite